The Valley Desk

Clinical trial reportInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPublished

Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Clinical trial report
Venue
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published
Subject terms
Humans; Endometrial Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Quality of Life; Adult; Aged; Middle Aged; Female; Microsatellite Instability
PubMed ID
39322611
Added to directory
Source checked

Report a correction or request removal